Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 315

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

Tiemann, Markus, Schrader, Carsten, Klapper, Wolfram, Dreyling, Martin H., Campo, Elias, Norton, Andrew, Berger, Francoise, Kluin, Philip, Ott, German, Pileri, Stephano, Pedrinis, Ennio, Feller, Alfred C., Merz, Hartmut, Janssen, Dirk, Hansmann, Martin L., van Krieken, Han, Möller, Peter, Stein, Harald, Unterhalt, Michael, Hiddemann, Wolfgang, Parwaresch, Reza·2005·British Journal of Haematology

Abstract

Summary: Mantle cell lymphoma (MCL) is a distinct lymphoma subtype with a particularly poor clinical outcome. The clinical relevance of the morphological characteristics of these tumours remains uncertain. The European MCL Network reviewed 304 cases of MCL to determine the prognostic significance of histopathological characteristics. Cytomorphological subtypes, growth pattern and markers of proliferation (mitotic and Ki‐67 indices) were analysed. In addition to the known cytological subtypes, classical (87·5%), small cell (3·6%), pleomorphic (5·9%) and blastic (2·6%), we identified new pleomorphic subgroups with mixtures of cells (classical + pleomorphic type; 1·6%) or transitions (classical/pleomorphic type; 1·6%), which, however, did not differ significantly in overall survival time. Exactly 80·5% of cases displayed a diffuse growth pattern, whereas 19·5% of cases had a nodular growth pattern, which was associated with a slightly more favourable prognosis. A high proliferation rate (mitotic or Ki‐67 indices) was associated with shorter overall survival. Cut‐off levels were defined that allowed three subgroups with different proliferation rates to be discriminated, which showed significantly different clinical outcomes (P < 0·0001). Based on this large clinicopathological study of prospective clinical trials, multivariate analysis confirmed the central prognostic role of cell proliferation and its superiority to all other histomorphological and clinical criteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2005.05716.x

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 315

Metadata

Authors
Tiemann, M., Schrader, C., Klapper, W., Dreyling, M. H., Campo, E., Norton, A., Berger, F., Kluin, P., Ott, G., Pileri, S., Pedrinis, E., Feller, A. C., Merz, H., Janssen, D., Hansmann, M. L., van Krieken, H., Möller, P., Stein, H., Unterhalt, M., Hiddemann, W., & Parwaresch, R.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2005-09-20
Volume
131
Issue
1
Pages
29-38
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1994161738
Cited by
315
References
23
FWCI
10.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. https://app.cochat.ai/papers/10.1111/j.1365-2141.2005.05716.x
The paper
Tiemann, M., Schrader, C., Klapper, W., Dreyling, M. H., Campo, E., Norton, A., Berger, F., Kluin, P., Ott, G., Pileri, S., Pedrinis, E., Feller, A. C., Merz, H., Janssen, D., Hansmann, M. L., van Krieken, H., Möller, P., Stein, H., Unterhalt, M., . . . Parwaresch, R. (2005). Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2005.05716.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.